Ascendis Pharma AS (ASND)
136.24
-1.50
(-1.09%)
USD |
NASDAQ |
Dec 20, 16:00
136.20
-0.04
(-0.03%)
After-Hours: 20:00
Ascendis Pharma Shareholders Equity (Quarterly): -108.70M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk AS | 18.05B |
| Evaxion Biotech AS | 0.074M |
| Trinity Biotech PLC | -26.34M |
| Akari Therapeutics PLC | -6.694M |
| Biodexa Pharmaceuticals PLC | 11.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.222B |
| Total Liabilities (Quarterly) | 1.330B |
| Debt to Equity Ratio | -8.104 |
| Current Ratio | 1.161 |
| Net Debt Paydown Yield | -0.74% |